Ischemic heart disease remains the most common cause of morbidity and mortality in Western societies, although the relative mortality attributable to it has decreased significantly in the last decade. The heart is highly vulnerable to oxygen deprivation, and occlusion of a major coronary artery is followed by myocardial metabolic and functional changes that develop rapidly after cessation of the blood flow. Restitution of the blood supply to an ischemic area is crucial for tissue survival; however, it also results in a cascade of harmful events that lead to what is known as the myocardial reperfusion injury. Its manifestations include arrhythmias, contractile dysfunction, endothelial dysfunction, and lethal reperfusion damage of cardiomyocytes. Since the size of the myocardial infarction is the major determinant of the subsequent development of the congestive heart failure, novel therapeutic treatments are focusing on limiting the extent of myocardial ischemia/reperfusion injury. Animal experimentations demonstrated that the reduction of infarct size can be achieved either pharmacologically or via the recruitment of powerful innate mechanisms, which are highly effective in protecting myocardial tissue against lethal ischemia/reperfusion injury and include ischemic and remote ischemic pre- and postconditioning. Although none of the identified pharmacological strategies have been successfully translated to the clinical setting, promising results of recent trials in patients with acute myocardial infarction ([@B4]) give hope that application of the remote ischemic conditioning procedure(s) may become a standard of care. In this review, we focus on these endogenous mechanisms of cardioprotection and discuss recent evidence suggesting that these phenomena are mediated (at least in part) via the recruitment of neural reflex mechanisms.

Neural Control of the Heart {#sec1}
===========================

Cardiac performance is controlled by the parasympathetic (inhibitory) and sympathetic (facilitatory) limbs of the autonomic nervous system. Sympathetic nerves innervate the sinoatrial and atrioventicular nodes, the atria, the ventricles, and the conducting tissue. Parasympathetic (vagal) efferent nerves are well known to control nodal tissues and atria, whereas the role of the parasympathetic innervation of the ventricles remains controversial. The majority of physiology textbooks teach that the vagal innervation of the ventricular system is sparse and that parasympathetic control of the ventricular contractility is insignificant. This view persists in both the scientific and educational literature, despite significant evidence obtained in various species (from rat to man) demonstrating the presence of choline acetyltransferase-positive nerve fibers, acetylcholinesterase enzyme, and muscarinic receptors in both the right and the left ventricles (recently reviewed in Ref. [@B8]). Functional data clearly demonstrate that increased activity of the vagus nerve decreases the force of ventricular contraction independent of its effect on heart rate \[see, for example, the papers by Xenopoulos and Applegate ([@B79]) and Lewis and colleagues ([@B41]) describing significant negative inotropic effect of the vagus nerve stimulation in the experiments conducted in dogs, pigs, and humans\].

The parasympathetic preganglionic neurones that innervate the heart are located in the medulla oblongata, and their axons travel in the vagus nerve to synapse on the parasympathetic efferent postganglionic neurones of the intrinsic cardiac ganglia ([FIGURE 1](#F1){ref-type="fig"}) ([@B30], [@B72]). Sympathetic preganglionic neurons of the spinal cord receive excitatory inputs from neurones located in the hypothalamus and the brain stem, and send their axons to postganglionic sympathetic neurones of the paravertebral ganglia innervating the heart ([FIGURE 1](#F1){ref-type="fig"}) ([@B15]). There is evidence that some sympathetic efferent postganglionic neurones may be located within the intrinsic cardiac ganglia, along with the parasympathetic postganglionic neurones ([FIGURE 1](#F1){ref-type="fig"}) (reviewed in Ref. [@B1]).

![Diagrammatic representation of sensory and efferent neural pathways controlling the heart\
AN, afferent (sensory) neurones; EPN, efferent parasympathetic neurones; ESN, efferent sympathetic neurones; IN, interneurones; SN, sympathoexcitatory neurones; SPN, sympathetic preganglionic neurones; VPN, vagal (parasympathetic) preganglionic neurones.](phy0021402050001){#F1}

The sensory innervation of the heart is provided by afferent neurones located in the nodose and the dorsal root ganglia. These neurones are responsible for sending information to the CNS, including brain stem areas involved in autonomic control, and their activation can trigger reflex changes in sympathetic and parasympathetic efferent outflows to the heart. Sensory neurones innervating the heart also have been identified in intrathoracic extracardiac ganglia and intrinsic cardiac ganglia ([@B1]) ([FIGURE 1](#F1){ref-type="fig"}). These sensory neurones are in a position to initiate local reflexes and, therefore, have a significant impact on heart rate and contractility via the modulation of the activity of efferent parasympathetic neurones located in the intrinsic cardiac ganglia ([@B1]).

Under resting conditions, the heart receives tonic influences from both sympathetic and parasympathetic efferent cardiac nerves, and it is generally believed that the control of the sympathetic and parasympathetic outflows to the heart is reciprocal in nature. The prevailing concept (conveyed by the physiology textbooks) of an autonomic balance postulates that activation of sympathetic or parasympathetic efferent limb is normally accompanied by inhibition of the other limb. This is certainly true for the operation of the baroreceptor reflex; however, there is evidence that some physiological responses may involve parallel co-activation of both sympathetic and parasympathetic drives to the heart (reviewed in Ref. [@B55]). Compared with vagal control, cardiac sympathetic innervation appeared relatively late in evolution \[it is not present in elasmobranch fish ([@B74])\], and concomitant activation of both autonomic limbs may be important to increase the "operational range" of the heart to meet metabolic demands of the body in ever-changing behavioral and environmental conditions.

Myocardial Ischemia and Reperfusion {#sec2}
===================================

Effect on Cardiomyocytes {#sec2-1}
------------------------

Myocardial ischemia leads to metabolic and functional changes, and its duration determines the size of the myocardial infarction ([@B28]). Restitution of blood supply to an ischemic myocardial area is, therefore, an absolute prerequisite for tissue survival, and the longer the duration of ischemia the less myocardial tissue is likely to survive following reperfusion ([@B21], [@B65]). The size of the infarct and its temporal evolution are also determined by the area of myocardial ischemia (perfusion territory of the coronary artery distal to the site of its occlusion), i.e., area at risk, the level of collateral blood flow ([@B46], [@B62]), and multiple other covariates (e.g., systemic hemodynamics) ([@B25]). In small rodent hearts with low collateral blood flow, relatively large infarct size (\>40% of the area at risk) is reached within 45--60 min of ischemia. In pigs, the time of infarct development is similar to that in rats. In dogs, collateral blood flow is relatively high, and infarction reaches ∼40% of the area at risk after 40 min of complete coronary occlusion and continues to develop over the next several hours ([@B63]). The time course of a first-time acute myocardial infarct evolution in humans appears to be significantly slower than in the most commonly used experimental animal models (including dogs) ([@B22]).

Treatment of acute ischemic damage has entered a new era, where patients\' morbidity and mortality have been dramatically reduced by procedures ensuring a rapid return of blood flow to the ischemic myocardium (i.e., reperfusion therapy). The importance of prompt reperfusion is defined by the axiom, "time is muscle and muscle is life" ([@B69]). However, restoration of blood flow also results in a cascade of harmful events that leads to so-called myocardial reperfusion injury, which involves myocardial cell death, defined as the death of the cardiomyocytes that are still viable at the end of the period of ischemia.

Effect on Cardiac Nervous System and Cardiac Reflexes {#sec2-2}
-----------------------------------------------------

Major autonomic and sensory (afferent) innervations of the heart receive their own rich blood supply arising from extracardiac sources ([@B27]). However, the activity patterns of the sensory nerves innervating the myocardium can be dramatically affected by ions and active molecules (e.g., purines, peptides, hydroxyl radical, lactate, and others) released in response to tissue ischemia and/or reperfusion ([@B1], [@B2]). For example, during ischemia in an anaesthetized rat model, adenosine and its breakdown products progressively accumulate in the myocardial interstitium and undergo rapid washout at the onset of reperfusion ([@B39]).

Activation of cardiac afferents during ischemia/reperfusion leads to reflex changes in parasympathetic and sympathetic outflows to the heart. Observations in dogs revealed that "sympathetic" afferents are mainly distributed throughout the anterior and inferoposterior walls of the left ventricle and that their activation during ischemia in both locations leads to an increase in sympathetic drive, as evidenced by increases in renal sympathetic nerve discharge ([@B49]). In another study, simultaneous recordings from two thoracic sympathetic cardiac nerves revealed differential changes in the activity patterns of fibers supplying ischemic (decreased activity) and nonischemic (no change or increased activity) myocardium ([@B53]). Sympathoexcitation, which accompanies myocardial ischemia, appears to be largely independent of baroreceptor reflex operation (reviewed in Ref. [@B47]).

Human data support the view that excitation of ventricular afferents is the predominant cause of general sympathetic activation, with similar increases in plasma norepinephrine observed in patients developing either anterior or inferior myocardial infarctions ([@B32]). In uncomplicated myocardial infarction, plasma norepinephrine concentration increases by approximately fivefold and is unlikely to have an adverse effect on myocardial function ([@B67]). However, reflex increases in cardiac sympathetic nerve activity combined with ischemia-induced reversed uptake may result in myocardial extracellular norepinephrine reaching \>100 times its normal plasma concentration within 30 min of ischemia ([@B67]).

Afferent fibers that when activated trigger vagally mediated responses appear to be located primarily in the inferoposterior walls of the left ventricle ([@B26]). Vagal effects are observed early after the onset of myocardial ischemia occurring within the posterior wall of the left ventricle, whereas sympathetic activation occurs with some delay after an onset of an acute myocardial infarction within the anterior wall ([@B44], [@B54]). These reports indicate that the distinct patterns of reflex sympathetic and parasympathetic responses triggered by myocardial ischemia are dependent on the area of the left ventricle affected and may have a significant impact on cardiac function and coronary blood flow.

Modulation of Myocardial Ischemia/Reperfusion Injury by Neural Mechanisms {#sec3}
=========================================================================

Norepinephrine (in small amounts) and acetylcholine released within the myocardium from sympathetic and parasympathetic efferent terminals may protect the myocytes against lethal ischemia/reperfusion injury. Stimulation of α-adrenoceptors under certain circumstances can result in cardioprotection. Intracoronary administration of α~1a~-adrenoceptor agonist methoxamine limits the infarct size in dogs subjected to regional ischemia and reperfusion ([@B36]). Stimulation of α~1b~-adrenoceptors with phenylephrine was also shown to reduce infarct size in a rabbit model ([@B75]).

Potent cardioprotection could be established by a prototypical effector molecule of the parasympathetic nervous system: acetylcholine (ACh). In several studies, ACh was shown to be as potent as adenosine in protecting the myocardium against lethal ischemia/reperfusion injury ([@B7], [@B59], [@B64], [@B80]). Cardioprotection induced by ACh appears to be mediated via activation of muscarinic receptors and subsequent modulation of the activity of ATP-dependent potassium channels ([@B7], [@B59], [@B80]).

A number of studies have determined the extent of myocardial ischemia/reperfusion injury in conditions when neural control of the heart is experimentally altered. Electrical stimulation of the vagus nerve was found to be highly effective in limiting myocardial ischemia/reperfusion injury ([@B6], [@B33]). In rats, dogs, and cats, stimulation of the vagus nerve was also found to prevent ventricular arrhythmias during myocardial ischemia associated with enhanced cardiac sympathetic activity ([@B9], [@B34], [@B50], [@B52], [@B82]). In a recent study, genetic targeting and highly selective stimulation of ∼300--400 vagal preganglionic neurones located in the dorsal motor nucleus of the vagus nerve (DVMN) resulted in a dramatic ∼50% reduction of myocardial ischemia/reperfusion injury in a rat model ([@B48]). The beneficial effect of vagus nerve or DVMN stimulation during an acute myocardial infarction is independent of heart rate modulation ([@B33], [@B48]) and is abolished by blockade of muscarinic receptors with atropine ([@B48]). Anti-fibrillatory effect of vagus nerve stimulation may also recruit a mechanism mediated by nitric oxide ([@B5]).

Experimental studies in dogs demonstrated that spinal cord stimulation (SCS) reduces the baseline activity of intrinsic sensory cardiac neurones and suppresses their activation triggered by ventricular ischemia and reperfusion ([@B13]). In a rabbit model of ischemia/reperfusion injury, SCS (dorsal C8--T2 segments) was found to reduce infarct size when initiated before, but not after, ischemia onset ([@B71]). Cardioprotection induced by SCS was abolished by α~1~-adrenoceptor blockade with prazosin and significantly reduced by β-adrenoceptor blockade with timolol ([@B71]). A more recent study using the same experimental model demonstrated significant cardioprotection elicited by SCS applied at the cervical level (C1--C2) ([@B70]). Cardioprotection induced by cervical cord stimulation was abolished by section of the cord dorsally at C6 level as well as by either muscarinic (atropine), β-adrenoceptor (atenolol), or α-adrenoceptor (prazosin, yohimbine) blockade ([@B70]).

Innate Mechanisms of Cardioprotection {#sec4}
=====================================

Paradoxically, if the myocardium is exposed to short, nonlethal ischemia-reperfusion episodes, it becomes "preconditioned." After such ischemic preconditioning (IPc), the myocardium becomes more tolerant to subsequent, much longer periods of ischemia. In a landmark study using anesthetized dogs, Murry et al. ([@B51]) demonstrated that four 5-min periods of left anterior descending coronary (LAD) artery occlusion, interspersed with 5-min reperfusion periods, resulted in profound reduction of the infarct size due to a subsequent 40-min-long occlusion of the same artery. IPc phenomenon was reproduced in a number of different experimental protocols in various species and with several endpoints of protection establishing IPc as a "gold standard" of cardioprotection.

Further experimental work has suggested that protective effects of IPc occur due to modulation of reperfusion injury, and consequently the idea suggesting that the preconditioning stimulus could only be effective when applied before ischemia was challenged ([@B56]). In the experiments using dogs, Zhao et al. ([@B81]) demonstrated a reduction in infarct size following three 30-s periods of LAD artery occlusion applied at the onset of reperfusion, which followed a 60-min occlusion period. The term "ischemic postconditioning" (IPost) was proposed to describe this protective phenomenon, and that study triggered significant interest in the opportunity of effectively targeting reperfusion injury if protective mechanisms of IPc and IPost are identified. However, widespread clinical use of IPc is difficult to implement due to unpredicted onset of the ischemic event and technical limitations requiring complex invasive procedures and application of direct myocardial ischemia.

Importantly, the myocardium can also be protected by remote ischemic preconditioning (RPc), the phenomenon in which cycles of brief ischemia and reperfusion of an organ or tissue protect a remote organ or tissue against ischemia/reperfusion injury. Przyklenk et al. ([@B58]) first demonstrated that brief ischemia of the circumflex artery reduced infarct size in the cardiac tissue supplied by the LAD artery. Subsequent studies have shown that cardioprotection can also be established by application of an ischemic stimulus to various organs distant to the heart (e.g., limbs and kidney). RPc results in the levels of protection comparable to that achieved by "classical" local IPc ([@B42], [@B76]) and at the level of the cardiomyocyte may recruit distinct or similar signaling pathways ([@B19], [@B23], [@B38], [@B76], [@B78]). Remarkably, myocardial ischemia/reperfusion injury can also be reduced by remote ischemic postconditioning, which confers even stronger cardioprotection than the IPost applied directly to the myocardium ([@B17]).

There is an ongoing debate on the mechanisms of how a "preconditioning stimulus" is relayed from the remote ischemic tissue/organ to the heart. Relay pathways of RPc-induced cardioprotection were suggested to involve humoral factor(s) produced during ischemia/reperfusion of the remote tissue and released into the systemic circulation ([@B20], [@B35], [@B37], [@B43], [@B68], [@B76]), or a neural component ([@B3], [@B11], [@B14], [@B31], [@B43], [@B45], [@B48], [@B73]), or both ([@B43], [@B61]).

Neural Mechanisms of Remote Ischemic Preconditioning Cardioprotection {#sec5}
=====================================================================

Gho et al. ([@B14]) demonstrated that the ganglion blocker hexamethonium abolishes cardioprotection established by RPc, providing the first evidence that neural (autonomic) pathways mediate this phenomenon. Subsequent studies reported that adenosine, bradykinin, and calcitonin gene-related peptide are all important components in the neural mechanisms underlying RPc ([@B66], [@B77]). The exact neural pathways remained unclear but appeared to be also important for human remote preconditioning, as demonstrated using the model of forearm ischemic endothelial injury assessed by flow-mediated dilation ([@B45]). On the other hand, an experimental study in pigs demonstrated that RPc (induced by transient limb ischemia) leads to a significant protection of the transplanted (i.e., completely denervated) heart ([@B37]). These data suggest that, in addition to a neural mechanism, a circulating substance (or a group of substances) may contribute to cardioprotective effects of RPc.

Indeed, plasma dialysate obtained from patients receiving RPc stimulus protects the rabbit heart (Langendorff preparation) against ischemia/reperfusion injury ([@B29]). Interestingly, plasma dialysates obtained from diabetic patients with peripheral neuropathy were not effective ([@B29]), supporting the idea that the release mechanism of preconditioning humoral factor(s) involves recruitment of a neural signaling pathway(s). Similar conclusions were also reached by Redington et al. ([@B61]), who demonstrated significant cardioprotection following application of plasma dialysates obtained from the experimental animals receiving RPc stimulus or following activation of the peripheral sensory fibers. Taken together, these data suggest that cardioprotection induced by RPc is dependent on particular experimental conditions and appears to be species and model dependent.

In an attempt to identify humoral factor(s) that mediate remote ischemic preconditioning, Lang et al. ([@B40]) performed proteomic analysis of the blood samples obtained from experimental animals subjected to myocardial ischemia/reperfusion injury with or without application of the RPc stimulus. The study failed to detect differential expression of proteins that possess a known signaling function and did not support the existence of a humoral mediator of RPc with a molecular weight of \>8 kDa ([@B40]). In contrast, a more recent study conducted in healthy adult volunteers reported that RPc evokes differential regulation (up- or downregulation) of various plasma proteins ([@B24]). Increases in the number of upregulated peptides was cumulative with each cycle of the arm ischemia/reperfusion. The proteins identified are linked to the control of the acute phase response and regulation of various cellular functions, suggesting that the humoral mechanisms that mediate RPc cardioprotection may involve complex interaction of multiple redundant signaling pathways.

The results of our studies using a rat model of myocardial ischemia/reperfusion injury confirmed that RPc stimulus applied to the limbs (induced by 15 min of occlusion of femoral arteries) significantly reduces myocardial ischemia/reperfusion injury ([@B3]). It was found that bilateral cervical vagotomy, surgical denervation of the ischemic limbs by sectioning the sciatic and femoral nerves, or permanent functional depletion of sensory nerves induced by neonatal systemic capsaicin (neurotoxin, the active component of chilli peppers) treatment effectively abolishes RPc cardioprotection ([@B3], [@B16]).

Interestingly, strong cardioprotection is elicited when capsaicin is applied topically to stimulate sensory neurones innervating remote organ/tissue ([@B3], [@B31], [@B61]). The same population of sensory fibers (nociceptors) are likely to be activated by trauma associated with surgical incision, which was found to induce potent cardioprotection of the mouse and canine hearts ([@B18], [@B31]). The type of sensory fibers, activation of which in response to tissue ischemia/reperfusion or trauma mediates cardioprotection, can be defined as "capsaicin-sensitive" afferents, C- and Aδ-fibers, which are excited (and at high doses destroyed) by capsaicin.

Failure of remote ischemia/reperfusion to establish cardioprotection in conditions of bilateral cervical vagotomy or systemic muscarinic receptor blockade with atropine ([@B3], [@B10], [@B16], [@B48]) suggests an important role of the parasympathetic nervous system in mediating the RPc phenomenon. This view is supported by human data showing that intermittent arm ischemia increases parasympathetic tone ([@B12]). This increase would be expected to have a beneficial effect on the heart in view of strong experimental evidence (reviewed above) demonstrating potent cardioprotection induced by vagus nerve stimulation ([@B6], [@B33]) or direct stimulation of vagal preganglionic neurones ([@B48]). A concept of a "remote preconditioning reflex" that involves sensory input from the remote ischemic organ/tissue and protects the heart via increased cardiac parasympathetic activity was recently proposed ([FIGURE 2](#F2){ref-type="fig"}) ([@B15]).

![Diagrammatic representation of a remote preconditioning reflex\
Remote ischemic preconditioning cardioprotection is hypothesized to be mediated via activation of a neural pathway comprising C-fiber sensory innervation of the remote ischemic organ/tissue and vagal innervation of the heart ([@B16]). Remote preconditioning of trauma may also involve sympathetic recruitment ([@B31]).](phy0021402050002){#F2}

A recent study attempted to disentangle humoral and neural mechanisms of RPc cardioprotection by targeted inhibition of a discrete central nervous substrate that generates parasympathetic tone. Cell-specific silencing of vagal preganglionic neurones located in the brain stem dorsal motor nucleus of the vagus nerve (DVMN) was achieved by transducing them with a viral vector to express an inhibitory *Drosophila* allatostatin receptor ([@B48]). RPc cardioprotection was completely abolished when transduced DVMN neurones were silenced by application of the selective ligand insect peptide allatostatin ([@B48]). These data revealed a crucial dependence of interorgan protection against ischemia/reperfusion injury upon the activity of a distinct population of vagal preganglionic neurones. DVMN neurones are believed to contribute to tonic C-fiber-mediated parasympathetic innervation of the heart ([@B30]), and that study also confirmed abundant cholinergic innervation of the rat left ventricle ([@B48]). These results do not exclude the involvement of humoral factor(s) but demonstrate that to establish cardioprotection a "humoral pathway" of RPc requires a certain level of activity of the DVMN vagal preganglionic neurones.

In conclusion, in this account, we have attempted to highlight the importance of neural mechanisms in protecting the heart against lethal myocardial ischemia/reperfusion injury. A large body of evidence demonstrates that the extent of myocardial infarction can be significantly reduced by experimentally induced changes in the activities of parasympathetic and sympathetic efferent fibers innervating the heart. Myocardial ischemia/reperfusion (via activation of cardiac afferents) and ischemia/reperfusion of tissues located remote from the heart (via activation of C-fiber afferents) can trigger distinct patterns of parasympathetic and sympathetic responses. The strength of these responses may be sufficient to establish cardioprotection, and it is conceivable that activation of these reflex pathways contribute to powerful innate mechanisms of cardioprotection underlying the (pre)conditioning phenomena. Promising results of clinical trials in patients with acute myocardial infarction ([@B4]) may lead to widespread introduction of remote ischemic conditioning procedure(s) into clinical practice. However, there are also negative reports ([@B57], [@B60]). Parasympathetic tone decreases with age and could be severely diminished or even absent in many disease states, perhaps rendering many patents insensitive to this procedure. We suggest that effective heart conditioning strategies should be capable of increasing cardiac parasympathetic activity and by doing so should be highly effective in reducing myocardial injury and decreasing morbidity and mortality of patients with ischemic heart disease.
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